By 
Women’s healthcare firm TherapeuticsMD Inc. has entered an agreement to be acquired by private equity firm EW Healthcare Partners in a deal that would value the company at $177 million.
Source: TherapeuticsMD
TXMD is up 353.74%, while IWM is down 0.99%.
Under the deal, EW Healthcare Partners is set to acquire all TXMD common stock at $10.00 per share, equivalent to a 367.3% premium over its closing price on May 27, 2022.
The transaction has been unanimously approved by TXMD’s Board of Directors in an all-cash tender offer that will remain open for 20 business days, subject to extension.
Following the tender offer, EW Healthcare Partners will take control of all remaining untendered shares of TXMD common stock also at $10.00 per share through a second-step merger.
The merger is expected to be completed by July 13, 2022, subject to conditions. It will entail TXMD becoming a privately held company, and its stock will no longer be listed on any public market.
Comments